Chaudhuri, A.; Kumar, D.N.; Srivastava, S.K.; Kumar, D.; Patil, U.K.; Parmar, A.S.; Singh, S.; Agrawal, A.K.
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics 2024, 16, 926.
https://doi.org/10.3390/pharmaceutics16070926
AMA Style
Chaudhuri A, Kumar DN, Srivastava SK, Kumar D, Patil UK, Parmar AS, Singh S, Agrawal AK.
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics. 2024; 16(7):926.
https://doi.org/10.3390/pharmaceutics16070926
Chicago/Turabian Style
Chaudhuri, Aiswarya, Dulla Naveen Kumar, Saurabh Kumar Srivastava, Dinesh Kumar, Umesh Kumar Patil, Avanish Singh Parmar, Sanjay Singh, and Ashish Kumar Agrawal.
2024. "Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach" Pharmaceutics 16, no. 7: 926.
https://doi.org/10.3390/pharmaceutics16070926
APA Style
Chaudhuri, A., Kumar, D. N., Srivastava, S. K., Kumar, D., Patil, U. K., Parmar, A. S., Singh, S., & Agrawal, A. K.
(2024). Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics, 16(7), 926.
https://doi.org/10.3390/pharmaceutics16070926
